HRT Financial’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$501K Buy
+12,191
New +$482K ﹤0.01% 2680
2025
Q4
– Sell
-107,525
Closed -$4.05M – 4021
2025
Q3
$4.05M Buy
+107,525
New +$3.93M 0.01% 782
2025
Q2
– Sell
-11,794
Closed -$380K – 3502
2025
Q1
$380K Buy
+11,794
New +$395K ﹤0.01% 1645

Other funds holding TCAF

HRT Financial's TCAF Position: Q2 2026 in Review

HRT Financial opened a new position in T. Rowe Price Capital Appreciation Equity ETF (TCAF) in Q2 2026: 12,191 shares worth $501K. The stake represents ﹤0.01% of the portfolio and ranks #2680 among its holdings. This is a return to the name: HRT Financial previously reported a position in TCAF as recently as Q3 2025.

HRT Financial first reported a position in TCAF in Q1 2025 and has held it in 3 quarters since. The position peaked at $4.05M in Q3 2025. 359 funds tracked by Wall St. Rank hold TCAF as of Q2 2026.

  • HRT Financial held 12,191 shares of T. Rowe Price Capital Appreciation Equity ETF worth $501K as of Q2 2026.
  • T. Rowe Price Capital Appreciation Equity ETF was a new HRT Financial position in Q2 2026.
  • T. Rowe Price Capital Appreciation Equity ETF made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2680 holding.
  • HRT Financial first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q1 2025 and has held it in 3 quarters since.
  • HRT Financial's T. Rowe Price Capital Appreciation Equity ETF position peaked at $4.05M in Q3 2025.
  • 359 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.